Document:

Trintech Group PLC 2009 Employee Share Purchase Plan.

 Exhibit 4.3 
 TRINTECH GROUP PLC 
 2009 EMPLOYEE SHARE PURCHASE PLAN 
 The following constitute the provisions of the 2009 Employee Share Purchase Plan of Trintech Group Plc. 
 1.     Purpose. The purpose of the Plan is to provide employees of the Company and its Designated Subsidiaries with an
opportunity to acquire Ordinary Shares of the Company through accumulated payroll deductions. It is the intention of the Company to have the Plan qualify as an “Employee Share Purchase Plan” under Section 423 of the Internal Revenue
Code of 1986, as amended (although the Company makes no undertaking or representation to maintain such qualification). The provisions of the Plan, accordingly, shall be construed so as to extend and limit participation in a manner consistent with
the requirements of that section of the Code. 
 2.     Definitions. 
 (a) “Board” shall mean the Board of Directors of the Company. 
 (b) “Code” shall mean the Internal Revenue Code of 1986, as amended. Any reference to a section of the Code herein will be a reference to
any successor or amended section of the Code. 
 (c) “Company” shall mean Trintech Group PLC, or any successor thereto.

 (d) “Compensation” shall mean an Employee’s base straight time gross earnings and commissions, but exclusive of
payments for overtime, shift premium, incentive compensation, incentive payments, bonuses and other compensation. 
 (e) “Designated
Subsidiary” shall mean any Subsidiary that has been designated by the Board from time to time in its sole discretion as eligible to participate in the Plan. 
 (f) “Employee” shall mean any individual who is a common law employee of an Employer for tax purposes whose customary employment with the Employer is at least twenty (20) hours per week and more
than five (5) months in any calendar year. For purposes of the Plan, the employment relationship shall be treated as continuing intact while the individual is on sick leave or other leave of absence approved by the Employer. Where the period of
leave exceeds 90 days and the individual’s right to reemployment is not guaranteed either by statute or by contract, the employment relationship shall be deemed to have terminated on the 91st day of such leave. The Board, in its discretion,
from time to time may, prior to an Enrollment Date for all options to be granted on such Enrollment Date, determine (on a uniform and nondiscriminatory basis) that the definition of Employee will or will not include an individual if he or she:
(i) has not completed at least two (2) years of service since his or her last hire date (or such lesser period of time as may be determined by the Board in its discretion), (ii) customarily works not more than twenty (20) hours
per week (or such lesser period of time as may be determined by the Board in its discretion), (iii) customarily works not more than five (5) months per calendar year (or such lesser period of time as may be determined by the Board in its
discretion), (iv) is an officer or other manager, or (v) is a highly compensated employee under Section 414(q) of the Code. 
 (g) “Employer” means any one or all of the Company and its Designated Subsidiaries. 
 (h) “Enrollment
Date” shall mean the first Trading Day of each Offering Period. 
 (i) “Exercise Date” shall mean the last Trading
Day of each Offering Period. The Board, in its discretion, from time to time may, prior to an Enrollment Date for all options to be granted on such Enrollment Date, determine (on a uniform and nondiscriminatory basis) when the Exercise Date will
occur during an Offering Period. 

 (j) “Fair Market Value” shall mean, as of any date, the value of the Ordinary Shares
determined as follows: 
 (i) If the Ordinary Shares are listed on any established stock exchange or a national market system, including
without limitation the Nasdaq Global Select Market, Nasdaq Global Market or Nasdaq Capital Market, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or
system for the last market Trading Day prior to the date of determination, as reported in The Wall Street Journal or such other source as the Board deems reliable; 
 (ii) If the Ordinary Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair Market Value shall be the mean of the closing bid and asked prices for the Ordinary
Shares on the last market Trading Day prior to the date of determination, as reported in The Wall Street Journal or such other source as the Board deems reliable; or 
 (iii) In the absence of an established market for the Ordinary Shares, the Fair Market Value thereof shall be determined in good faith by the Board;

 (k) “Offering Periods” shall mean the periods of approximately six (6) months during which an option granted pursuant
to the Plan may be exercised, commencing on (i) the first Trading Day on or after March 1 of each year and terminating on the last Trading Day in the Offering Period ending the following August 31, approximately six (6) months
later, and (ii) commencing on the first Trading Day on or after September 1 of each year and terminating on the last Trading Day in the Offering Period ending the following February 28 (or February 29, as applicable)
approximately six (6) months later. The duration and timing of Offering Periods may be changed pursuant to Sections 4 and 20 of this Plan. 
 (l) “Ordinary Shares” shall mean the ordinary shares of the Company. 
 (m) “Parent” means a
“parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code. 
 (n)
“Plan” shall mean this 2009 Employee Share Purchase Plan. 
 (o) “Purchase Price” shall mean 85% of the Fair
Market Value of an Ordinary Share on the Enrollment Date or on the Exercise Date, whichever is lower; provided however, that in no event shall the Purchase Price be less than the par value of an Ordinary Share and, provided further, that the
Purchase Price may be adjusted by the Board pursuant to Section 20. 
 (p) “Reserves” shall mean the number of Ordinary
Shares covered by each option under the Plan which have not yet been exercised and the number of Ordinary Shares which have been authorized for issuance under the Plan but not yet placed under option. 
 (q) “Subsidiary” shall mean a “subsidiary corporation,” whether now or hereafter existing, as defined in Section 424(f) of
the Code. 
 (r) “Trading Day” shall mean a day on which national stock exchanges and a national trading system are open for
trading. 
 3.     Eligibility. 
 (a) Any Employee who shall be employed by the Employer on a given Enrollment Date shall be eligible to participate in the Plan, subject to the requirements of Section 5. 
 (b) Any provisions of the Plan to the contrary notwithstanding, no Employee shall be granted an option under the Plan (i) to the extent that,
immediately after the grant, such Employee (or any other person whose shares would be attributed to such Employee pursuant to Section 424(d) of the Code) would own issued capital shares of the Company or any Parent or Subsidiary and/or hold
outstanding options to acquire such shares possessing five percent (5%) or more of the total 

  

 -2- 

 
combined voting power or value of all classes of the capital shares of the Company or of any Parent or Subsidiary, or (ii) to the extent that his or her
rights to acquire shares under all employee share purchase plans of the Company and any Parent or Subsidiary accrues at a rate which exceeds Twenty-Five Thousand Dollars ($25,000) worth of shares (determined at the fair market value of the shares at
the time such option is granted) for each calendar year in which such option is outstanding at any time, as determined in accordance with Section 423 of the Code and the regulations thereunder. 
 4.    Offering Periods. The Plan shall be implemented by consecutive Offering Periods with a new Offering Period commencing on
the first Trading Day on or after March 1 and September 1 each year, or on such other date as the Board shall determine, and continuing thereafter until terminated in accordance with Section 20 hereof. The Board shall have the power
to change the duration of Offering Periods (including the commencement dates thereof) with respect to future offerings without shareholder approval if such change is announced at least five (5) days prior to the scheduled beginning of the first
Offering Period to be affected thereafter. 
 5.    Participation. 
 (a) An eligible Employee may become a participant in the Plan by (i) completing a subscription agreement authorizing payroll deductions in the form
of Exhibit A to this Plan and filing it with the Company’s payroll office (or its designee) prior to the applicable Enrollment Date or (ii) following an electronic or other enrollment procedure determined by the Company. 

(b) Payroll deductions for a participant shall commence on the first payroll following the Enrollment Date and shall end on the last payroll in the
Offering Period to which such authorization is applicable, unless sooner terminated by the participant as provided in Section 10 hereof. 
 6.    Payroll Deductions. 
 (a) At the time a participant enrolls in the Plan, he or she shall elect to
have payroll deductions made on each pay day during the Offering Period (subject to Section 5(b)) in an amount not exceeding fifteen percent (15%) of the Compensation which he or she receives on each pay day during the Offering Period.

 (b) All payroll deductions made for a participant shall be credited to his or her account under the Plan and shall be withheld in whole
percentages only. A participant may not make any additional payments into such account. 
 (c) A participant may discontinue his or her
participation in the Plan as provided in Section 10 hereof, or may increase or decrease the rate of his or her payroll deductions during the Offering Period by (i) properly completing and filing with the Company (or its designee) a new
subscription agreement authorizing a change in payroll deduction rate or (ii) following an electronic or other procedure prescribed by the Company. If a participant has not followed such procedures to change the rate of payroll deductions, the
rate of his or her payroll deductions will continue at the originally elected rate throughout the Offering Period and future Offering Periods (unless terminated as provided in Section 10). The Board may, in its discretion, limit the number of
participation rate changes during any Offering Period and may establish such other conditions or limitations as it deems appropriate for Plan administration. The change in rate shall be effective with the first full payroll period following five
(5) business days after the Company’s (or its designee’s) receipt of the new subscription agreement or the participant’s completion of an electronic or other procedure prescribed by the Company unless the Company elects to
process a given change in participation more quickly. A participant’s subscription agreement shall remain in effect for successive Offering Periods unless terminated as provided in Section 10 hereof. 
  

 -3- 

 (d) Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b) (8) of
the Code and Section 3(b) hereof, a participant’s payroll deductions may be decreased to zero percent (0%) at any time during an Offering Period. Subject to Section 423(b)(8) of the Code and Section 3(b) hereof, payroll
deductions shall recommence at the rate provided in such participant’s subscription agreement at the beginning of the first Offering Period which is scheduled to end in the following calendar year, unless terminated by the participant as
provided in Section 10 hereof. 
 (e) At the time the option is exercised, in whole or in part, or at the time some or all of the
Company’s Ordinary Shares issued under the Plan is disposed of, the participant must make adequate provision for the Company’s or Employer’s federal, state, or other tax withholding obligations, if any, which arise upon the exercise
of the option or the disposition of the Ordinary Shares. At any time, the Company or the Employer may, but shall not be obligated to, withhold from the participant’s compensation the amount necessary for the Company or the Employer to meet
applicable withholding obligations, including any withholding required to make available to the Company or the Employer any tax deductions or benefits attributable to sale or early disposition of Ordinary Shares by the Employee. In addition, the
Company or the Employer may, but will not be obligated to, withhold from the proceeds of the sale of Ordinary Shares or any other method of withholding the Company or the Employer deems appropriate. 
 7.    Grant of Option. On the Enrollment Date of each Offering Period, each eligible Employee participating in such Offering
Period shall be granted an option to acquire on the Exercise Date of such Offering Period (at the applicable Purchase Price) up to a number of shares of the Company’s Ordinary Shares determined by dividing such Employee’s payroll
deductions accumulated prior to such Exercise Date and retained in the Participant’s account as of the Exercise Date by the applicable Purchase Price; provided that in no event shall an Employee be permitted to acquire during each Offering
Period more than 10,000 of the Company’s Ordinary Shares (subject to any adjustment pursuant to Section 19), and provided further that such acquisition shall be subject to the limitations set forth in Sections 3(b) and 12 hereof. The
Board may, for future Offering Periods, increase or decrease, in its absolute discretion, the maximum number of the Company’s Ordinary Shares an Employee may acquire during each Offering Period. Exercise of the option shall occur as provided in
Section 8 hereof, unless the participant has withdrawn pursuant to Section 10 hereof. The option shall expire on the last day of the Offering Period. 
 8.    Exercise of Option. 
 (a) Unless a participant withdraws from the Plan as
provided in Section 10 hereof, his or her option for the acquisition of shares shall be exercised automatically on the Exercise Date, and the maximum number of full shares subject to option shall be acquired for such participant at the
applicable Purchase Price with the accumulated payroll deductions in his or her account. No fractional shares shall be acquired; any payroll deductions accumulated in a participant’s account which are not sufficient to acquire a full share
shall be retained in the participant’s account for the subsequent Offering Period, subject to earlier withdrawal by the participant as provided in Section 10 hereof. Any other monies left over in a participant’s account after the
Exercise Date shall be returned to the participant. During a participant’s lifetime, a participant’s option to acquire shares hereunder is exercisable only by him or her. 
 (b) If the Board determines that, on a given Exercise Date, the number of shares with respect to which options are to be exercised may exceed (i) the
number of Ordinary Shares that were available for sale under the Plan on the Enrollment Date of the applicable Offering Period, or (ii) the number of shares available for sale under the Plan on such Exercise Date, the Board may in 

  

 -4- 

 
its sole discretion (x) provide that the Company shall make a pro rata allocation of the Ordinary Shares available for acquisition on such Enrollment
Date or Exercise Date, as applicable, in as uniform a manner as shall be practicable and as it shall determine in its sole discretion to be equitable among all participants exercising options to acquire Ordinary Shares on such Exercise Date, and
continue the Offering Period then in effect, or (y) provide that the Company shall make a pro rata allocation of the shares available for acquisition on such Enrollment Date or Exercise Date, as applicable, in as uniform a manner as shall be
practicable and as it shall determine in its sole discretion to be equitable among all participants exercising options to acquire Ordinary Shares on such Exercise Date, and terminate any Offering Period then in effect pursuant to Section 20
hereof. The Company may make pro rata allocation of the shares available on the Enrollment Date of any applicable Offering Period pursuant to the preceding sentence, notwithstanding any authorization of additional shares for issuance under the Plan
by the Company’s shareholders subsequent to such Enrollment Date. 
 9.    Delivery. Shares acquired by a
participant upon exercise of his or her option shall, at the election of the participant, be issued (i) in the name of the participant or the participant and the participant’s spouse, or (ii) in the name of AIB Custodial Nominees
Limited, having its registered office at P.O. Box 518, IFSC, Dublin 1, Ireland, to hold the shares as nominee and on behalf of the participant and subject to the participant’s instructions. 
 10.    Withdrawal. 
 (a) A participant may withdraw all but not less than all the payroll deductions credited to his or her account and not yet used to exercise his or her option under the Plan at any time by (i) giving written notice to the Company (or
its designee) in the form of Exhibit B to this Plan or (ii) following an electronic or other withdrawal procedure determined by the Company. All of the participant’s payroll deductions credited to his or her account shall be paid to
such participant promptly after receipt of notice of withdrawal and such participant’s option for the Offering Period shall be automatically terminated, and no further payroll deductions for the acquisition of shares shall be made for such
Offering Period. If a participant withdraws from an Offering Period, payroll deductions shall not resume at the beginning of the succeeding Offering Period unless the participant re-enrolls in the Plan in accordance with the provisions of
Section 5. 
 (b) A participant’s withdrawal from an Offering Period shall not have any effect upon his or her eligibility to
participate in any similar plan which may hereafter be adopted by the Company or in succeeding Offering Periods which commence after the termination of the Offering Period from which the participant withdraws. 
 11.    Termination of Employment. 
 Upon a participant’s ceasing to be an Employee, for any reason, he or she shall be deemed to have elected to withdraw from the Plan and the payroll deductions credited to such participant’s account during
the Offering Period but not yet used to exercise the option shall be returned to such participant or, in the case of his or her death, to the person or persons entitled thereto under Section 15 hereof, and such participant’s option shall
be automatically terminated. The preceding sentence notwithstanding, a participant who receives payment in lieu of notice of termination of employment shall be treated as continuing to be an Employee for the participant’s customary number of
hours per week of employment during the period in which the participant is subject to such payment in lieu of notice. 
 12.    Interest. No interest shall accrue on the payroll deductions of a participant in the Plan. 
 13.    Stock. 
  

 -5- 

 (a) Subject to adjustment upon changes in capitalization of the Company as provided in Section 19
hereof, the maximum number of shares of the Company’s Ordinary Shares which shall be made available for acquisition under the Plan shall be 200,000 ADR (400,000 Ordinary Shares). Until the shares are issued (as evidenced by the appropriate
entry on the books of the Company or of a duly authorized transfer agent of the Company), a participant will only have the rights of an unsecured creditor with respect to such shares, and no right to vote or receive dividends or any other rights as
a stockholder will exist with respect to such shares. 
 (b) Ordinary Shares to be delivered to a participant under the Plan shall be
registered in the name of the participant or in the name of the participant and his or her spouse. 
 14.    Administration. The Plan shall be administered by the Board or a committee of members of the Board appointed by the Board. The Board or its committee shall have full and exclusive discretionary authority to
construe, interpret and apply the terms of the Plan, to determine eligibility and to adjudicate all disputed claims filed under the Plan. Every finding, decision and determination made by the Board or its committee shall, to the full extent
permitted by law, be final and binding upon all parties. Notwithstanding any provision to the contrary in this Plan, the Board or a committee appointed by the Board may adopt rules or procedures relating to the operation and administration of the
Plan to accommodate the specific requirements of local laws and procedures for jurisdictions outside of the United States. Without limiting the generality of the foregoing, the Board or a committee appointed by the Board is specifically authorized
to adopt rules and procedures regarding eligibility to participate, the definition of Compensation, handling of payroll deductions, making of contributions to the Plan (including, without limitation, in forms other than payroll deductions),
establishment of bank or trust accounts to hold payroll deductions, payment of interest, conversion of local currency, obligations to pay payroll tax, determination of beneficiary designation requirements, withholding procedures and handling of
stock certificates which vary with local requirements. 
 15.    Designation of Beneficiary. 
 (a) A participant who is employed and domiciled in the United States may file a written designation of a beneficiary who is to receive any shares and
cash, if any, from the participant’s account under the Plan in the event of such participant’s death subsequent to an Exercise Date on which the option is exercised but prior to delivery to such participant of such shares and cash. In
addition, a participant who is employed and domiciled in the United States may file a written designation of a beneficiary who is to receive any cash from the participant’s account under the Plan in the event of such participant’s death
prior to exercise of the option. If a participant is married and the designated beneficiary is not the spouse, spousal consent shall be required for such designation to be effective. 
 (b) Such designation of beneficiary may be changed by the participant at any time by written notice. In the event of the death of a participant and in the
absence of a beneficiary validly designated under the Plan who is living at the time of such participant’s death, the Company shall deliver such shares and/or cash to the executor or administrator of the estate of the participant, or if no such
executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares and/or cash to the spouse or to any one or more dependents or relatives of the participant, or if no spouse,
dependent or relative is known to the Company, then to such other person as the Company may designate. 
 (c) All beneficiary designations
will be in such form and manner as the Company may designate from time to time. 
  

 -6- 

 16.    Transferability. Neither payroll deductions credited to a
participant’s account nor any rights with regard to the exercise of an option or to receive shares under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and
distribution or as provided in Section 15 hereof) by the participant. Any such attempt at assignment, transfer, pledge or other disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds
from an Offering Period in accordance with Section 10 hereof. 
 17.    Use of Funds. All payroll deductions
received or held by the Company under the Plan may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such payroll deductions. 
 18.    Reports. Individual accounts shall be maintained for each participant in the Plan. Statements of account shall be given
to participating Employees at least annually, which statements shall set forth the amounts of payroll deductions, the Purchase Price, the number of shares acquired and the remaining cash balance, if any. 
 19.    Adjustments Upon Changes in Capitalization, Dissolution, Liquidation, Merger or Asset Sale. 
 (a) Changes in Capitalization. Subject to any required action by the shareholders of the Company, the Reserves, the maximum number of shares each
participant may acquire each Offering Period (pursuant to Section 7), as well as the price per share and the number of Ordinary Shares covered by each option under the Plan which has not yet been exercised shall be proportionately adjusted for
any increase or decrease in the number of issued Ordinary Shares resulting from a share split, reverse share split, share dividend, combination or reclassification of the Ordinary Shares, or any other increase or decrease in the number of Ordinary
Shares effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.” Such adjustment
shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall
affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Ordinary Shares subject to an option. 
 (b)
Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Offering Period then in progress shall be shortened by setting a new Exercise Date (the “New Exercise Date”), and shall
terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the Board. The New Exercise Date shall be before the date of the Company’s proposed dissolution or liquidation. The Board
shall notify each participant in writing, at least ten (10) business days prior to the New Exercise Date, that the Exercise Date for the participant’s option has been changed to the New Exercise Date and that the participant’s option
shall be exercised automatically on the New Exercise Date, unless prior to such date the participant has withdrawn from the Offering Period as provided in Section 10 hereof. 
 (c) Merger or Asset Sale. In the event of a sale of all or substantially all of the assets of the Company, or the merger of the Company with or
into another corporation, each outstanding option shall be assumed or an equivalent option substituted by the successor corporation or a Parent or Subsidiary of the successor corporation. In the event that the successor corporation refuses to assume
or substitute for the option, any Offering Periods then in progress shall be shortened by setting a new Exercise Date (the “New Exercise Date”) and any Offering Periods then in progress shall end on the New Exercise Date. The New Exercise
Date shall be before the date of 

  

 -7- 

 
the Company’s proposed sale or merger. The Board shall notify each participant in writing, at least ten (10) business days prior to the New
Exercise Date, that the Exercise Date for the participant’s option has been changed to the New Exercise Date and that the participant’s option shall be exercised automatically on the New Exercise Date, unless prior to such date the
participant has withdrawn from the Offering Period as provided in Section 10 hereof. 
 20.    Amendment or
Termination. 
 (a) The Board of Directors of the Company may at any time and for any reason terminate, suspend or amend the Plan, or any
part thereof, at any time and for any reason. Except as provided in Section 19 hereof, no such termination can affect options previously granted, provided that an Offering Period may be terminated by the Board of Directors on any Exercise Date
if the Board determines that the termination of the Offering Period or the Plan is in the best interests of the Company and its shareholders. Except as provided in Section 19 and this Section 20 hereof, no amendment may make any change in
any option theretofore granted which adversely affects the rights of any participant. To the extent necessary to comply with Section 423 of the Code (or any successor rule or provision or any other applicable law, regulation or stock exchange
rule), the Company shall obtain shareholder approval in such a manner and to such a degree as required. 
 (b) Without shareholder consent and
without regard to whether any participant rights may be considered to have been “adversely affected,” the Board (or its committee) shall be entitled to change the Offering Periods, limit the frequency and/or number of changes in the amount
withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit payroll withholding in excess of the amount designated by a participant in order to adjust for delays or
mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the acquisition of Ordinary
Shares for each participant properly correspond with amounts withheld from the participant’s Compensation, and establish such other limitations or procedures as the Board (or its committee) determines in its sole discretion advisable which are
consistent with the Plan. 
 (c) In the event the Board determines that the ongoing operation of the Plan may result in unfavorable financial
accounting consequences, the Board may, in its discretion and, to the extent necessary or desirable, modify or amend the Plan to reduce or eliminate such accounting consequence including, but not limited to: 
 (i) altering the Purchase Price for any Offering Period including an Offering Period underway at the time of the change in Purchase Price; 
 (ii) shortening any Offering Period so that Offering Period ends on a new Exercise Date, including an Offering Period underway at the time of the Board
action; 
 (iii) allocating shares; 
 (iv) amending the Plan to conform with the safe harbor definition under Statement of Financial Accounting Standards 123(R), including with respect to an Offering Period underway at the time; and 
 (v) reducing the maximum percentage of Compensation a participant may elect to set aside as payroll deductions. 
 Such modifications or amendments shall not require stockholder approval or the consent of any Plan participants. 
 21.    Notices. All notices or other communications by a participant to the Company under or in connection with the Plan shall
be deemed to have been duly given when received in the form 

  

 -8- 

 
specified by the Company at the location, or by the person, designated by the Company for the receipt thereof. 
 22.    Conditions Upon Issuance of Shares. Shares shall not be issued with respect to an option unless the exercise of such
option and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, as amended, the Securities Exchange Act of 1934,
as amended, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such
compliance. 
 As a condition to the exercise of an option, the Company may require the person exercising such option to represent and
warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by
any of the aforementioned applicable provisions of law. 
 23.    Term of Plan. The Plan shall become effective
upon the earlier to occur of its adoption by the Board of Directors or its approval by the shareholders of the Company. It shall continue in effect for a term of ten (10) years unless sooner terminated under Section 20 hereof. 

 

 -9- 

 EXHIBIT A 
 TRINTECH GROUP PLC 
 2009 EMPLOYEE SHARE PURCHASE PLAN 
 SUBSCRIPTION AGREEMENT 
  

					
	______ Original Application	 		 	Enrollment Date: ___________
	______ Change in Payroll Deduction Rate	 		 	
	______ Change of Beneficiary(ies)	 		 	

  

	1.	____________________ hereby elects to participate in the Trintech Group PLC 2009 Employee Share Purchase Plan (the “Employee Share Purchase Plan”) and subscribes to
acquire shares of the Company’s Ordinary Shares in accordance with this Subscription Agreement and the Employee Share Purchase Plan. 

	2.	I hereby authorize payroll deductions from each paycheck in the amount of ____% of my Compensation on each payday (from 1 to 15%) during the Offering Period in accordance with the
Employee Share Purchase Plan. (Please note that no fractional percentages are permitted.) 

	3.	I understand that said payroll deductions shall be accumulated for the acquisition of Ordinary Shares at the applicable Purchase Price determined in accordance with the Employee
Share Purchase Plan. I understand that if I do not withdraw from an Offering Period, any accumulated payroll deductions will be used to automatically exercise my option and purchase Ordinary Shares under the Employee Share Purchase Plan.

	4.	I have received a copy of the complete Employee Share Purchase Plan. I understand that my participation in the Employee Share Purchase Plan is in all respects subject to the terms
of the Plan. I understand that my ability to exercise the option under this Subscription Agreement is subject to shareholder approval of the Employee Share Purchase Plan. 

	5.	Shares acquired for me under the Employee Share Purchase Plan should be issued in the name(s) of ______________________ (Employee or Employee and Spouse only).

	6.	 I understand that if I dispose of any shares received by me pursuant to the Employee Share Purchase Plan within 2 years after the Enrollment Date (the first day of
the Offering Period during which I purchased such shares) or one year after the Exercise Date, I will be treated for federal income tax purposes as having received ordinary income at the time of such disposition in an amount equal to the excess of
the fair market value of the shares at the time such shares were acquired by me over the price which I paid for the shares. I hereby agree to notify the Company in writing within 30 days after the date of any disposition of my shares and I will
make adequate provision for Federal, state or other tax withholding obligations, if any, which arise upon the disposition of the Ordinary Shares. The Company may, but will not be obligated to, withhold from my compensation the amount necessary
to meet any applicable withholding obligation including any withholding necessary to make available to the Company any tax deductions or benefits attributable to sale or early disposition of Ordinary Shares by me. If I dispose of such shares at any
time after the expiration of the 2-year and 1-year holding periods, I understand that I will be treated for federal income tax purposes as having received income only at the time of such disposition, and that such 

	 	 
income will be taxed as ordinary income only to the extent of an amount equal to the lesser of (1) the excess of the fair market value of the shares at
the time of such disposition over the acquisition price which I paid for the shares, or (2) 15% of the fair market value of the shares on the first day of the Offering Period. The remainder of the gain, if any, recognized on such disposition
will be taxed as capital gain. 

	7.	I hereby agree to be bound by the terms of the Employee Share Purchase Plan. The effectiveness of this Subscription Agreement is dependent upon my eligibility to participate in the
Employee Share Purchase Plan. 

	8.	In the event of my death, I hereby designate the following as my beneficiary(ies) to receive all payments and shares due me under the Employee Share Purchase Plan:

  

							
	 NAME: (Please print)_____________________________________________________________________________

		  	(First)	  	(Middle)	  	(Last)

  

					
	 _____________________________
	 		  	__________________________________________________
	 Relationship
	 		  	
		 		  	__________________________________________________
		 		  	(Address)
		 		  	
		 		  	
	 Employee’s Social
	 		  	
	 Security Number:
	 		  	_____________________________________________
	 Employee’s Address:
	 		  	_____________________________________________
		 		  	_____________________________________________
		 		  	_____________________________________________

 I UNDERSTAND THAT THIS SUBSCRIPTION AGREEMENT SHALL REMAIN IN EFFECT THROUGHOUT SUCCESSIVE OFFERING PERIODS UNLESS
TERMINATED BY ME. 
  

					
	Dated:_________________________	  		  	__________________________________________________
		  		  	Signature of Employee
		  		  	
		  		  	
		  		  	__________________________________________________
		  		  	Spouse’s Signature (If beneficiary other than spouse)

  

 -2- 

 EXHIBIT B 
 TRINTECH GROUP PLC 
 2009 EMPLOYEE SHARE PURCHASE PLAN 
 NOTICE OF WITHDRAWAL 
 The undersigned participant in
the Offering Period of the Trintech Group PLC 2009 Employee Share Purchase Plan which began on
                             ,              (the
“Enrollment Date”) hereby notifies the Company that he or she hereby withdraws from the Offering Period. He or she hereby directs the Company to pay to the undersigned as promptly as practicable all the payroll deductions credited to his
or her account with respect to such Offering Period. The undersigned understands and agrees that his or her option for such Offering Period will be automatically terminated. The undersigned understands further that no further payroll deductions will
be made for the acquisition of shares in the current Offering Period and the undersigned shall be eligible to participate in succeeding Offering Periods only by delivering to the Company a new Subscription Agreement. 
  

			
	Name and Address of Participant:
		
	  	 	  
		
	  	 	  
		
	  	 	  
		 	
	
	Signature:
	
	  
		
	Date:Form of Restricted Stock Award and Cash Performance Award

 EXHIBIT 10.1 
 HEALTH MANAGEMENT ASSOCIATES, INC. 
 1996 EXECUTIVE INCENTIVE COMPENSATION PLAN 
 AWARD NOTICE 
  

			
	Grantee:	  	  

		
	Types of Awards:	  	 Restricted Stock Award consisting of two components:
  
 (i) a Time Vesting Component equal to one-half of the Number of Shares; and
  
 (ii) a Performance Vesting Component equal to one-half of the Number of Shares.

  
 Cash Performance Award

		
	Number of Shares:	  	  

		
	Cash Amount:	  	  

		
	Date of Grant:	  	  

 1. Grant of Award. This Award Notice serves to notify you that the Compensation Committee
(the “Committee”) of the Board of Directors of Health Management Associates, Inc. (“HMA”) hereby grants to you, under HMA’s Amended and Restated 1996 Executive Incentive Compensation Plan (the “Plan”): (a) a
restricted stock award for the Number of Shares of HMA’s Class A Common Stock, par value $0.01 per share (the “Common Stock”) set forth above consisting of a time vesting component (the “Time Vesting Component”), and a
performance vesting component (the “Performance Vesting Component,” and together with the Time Vesting Component, the “Restricted Stock Award”); and (b) a cash performance award for the Cash Amount set forth above (the
“Cash Performance Award,” and together with the Restricted Stock Award, the “Award”), each on the terms and conditions set forth in this Award Notice and the Plan. The Plan is incorporated herein by reference and made a part of
this Award Notice. A copy of the Plan is available from HMA’s Human Resources Department upon request. You should review the terms of this Award Notice and the Plan carefully. The capitalized terms used and not defined in this Award Notice are
defined in the Plan. 
 2. Definitions. The following terms have the meanings set forth in this Section 2: 
 (a) “EBITDA” means, with respect to the First Grant Year (and if applicable, the Second Grant Year), HMA’s earnings before
interest, income taxes, depreciation, amortization and non-controlling interests for that Grant Year, as adjusted to exclude unusual and non-recurring items for that Grant Year. 
 (b) “EBITDA Requirement” means the achievement by HMA, as determined by the Committee, of EBITDA in an amount equal to the necessary
percentage of Targeted EBITDA as set forth in the following table: 
  

			
	 Percentage of Targeted EBITDA
 Achieved During Grant Year
	 	Percentage of EBITDA-Based
Performance Awards Eligible For
Vesting
	Less than 90.0%	 	0%
	90.0% - 92.4%	 	50%
	92.5% - 94.9%	 	60%
	95.0% - 97.4%	 	75%
	97.5% - 99.9%	 	90%
	100.0% (and over)	 	100%

 (c) “Employer” means HMA or one of its subsidiary hospitals or other majority-owned or
affiliated entities. 
 (d) “Fifth Grant Year” means the fiscal year of HMA immediately following the conclusion of the
Fourth Grant Year. 
 (e) “First Grant Year” means the fiscal year of HMA during which the Date of Grant occurs. 

(f) “Fourth Grant Year” means the fiscal year of HMA immediately following the conclusion of the Third Grant Year. 
 (g) “Grant Year” means the First Grant Year, Second Grant Year, Third Grant Year, Fourth Grant Year and/or Fifth Grant Year, as the
context suggests. 
 (h) “Second Grant Year” means the fiscal year of HMA immediately following the conclusion of the First
Grant Year. 
 (i) “Targeted EBITDA” means the total targeted annual EBITDA established by HMA’s Board of Directors as
reflected in its approved profit plan for the First Grant Year and, if applicable, the Second Grant Year. 
 (j) “Third Grant
Year” means the fiscal year of HMA immediately following the conclusion of the Second Grant Year. 
 3. Time Vesting
Component. Subject to the terms set forth in this Award Notice and the Plan, the number of shares of the Common Stock represented by the Time Vesting Component of the Restricted Stock Award (the “Time-Based Shares”) will vest as
follows: 
 (a) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Second Grant
Year, one-fourth of the Time-Based Shares will vest on March 1 of the Second Grant Year; 
 (b) provided that you have remained an
Eligible Person at all times from the Date of Grant until March 1 of the Third Grant Year, an additional one-fourth of the Time-Based Shares will vest on March 1 of the Third Grant Year; 
  

 2 

 (c) provided that you have remained an Eligible Person at all times from the Date of Grant until
March 1 of the Fourth Grant Year, an additional one-fourth of the Time-Based Shares will vest on March 1 of the Fourth Grant Year; and 
 (d) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Fifth Grant Year, the remaining one-fourth of the Time-Based Shares will vest on March 1 of the Fifth Grant Year.

 4. Performance Vesting Component. Subject to the terms set forth in this Award Notice and the Plan, including Committee
certification pursuant to Section 6, the number of shares of the Common Stock represented by the Performance Vesting Component of the Restricted Stock Award (the “Performance Shares”) will vest as follows: 
 (a) Earned Performance Shares. At the conclusion of the First Grant Year, all or a portion of the Performance Shares will be eligible for
vesting based upon the achievement by HMA of the EBITDA Requirement during the First Grant Year. The portion of the Performance Shares that is eligible for vesting based upon the achievement by HMA of the EBITDA Requirement during the First Grant
Year is referred to herein as the “Earned Performance Shares.” The Earned Performance Shares will vest as follows: 
 (i) provided
that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Second Grant Year, one-fourth of the Earned Performance Shares will vest on March 1 of the Second Grant Year; 
 (ii) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Third Grant Year, an additional
one-fourth of the Earned Performance Shares will vest on March 1 of the Third Grant Year; 
 (iii) provided that you have remained an
Eligible Person at all times from the Date of Grant until March 1 of the Fourth Grant Year, an additional one-fourth of the Earned Performance Shares will vest on March 1 of the Fourth Grant Year; and 
 (iv) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Fifth Grant Year, the remaining
one-fourth of the Earned Performance Shares will vest on March 1 of the Fifth Grant Year. 
 (b) Additional Earned Performance
Shares. In the event that all or any portion of the Performance Shares is not deemed Earned Performance Shares because HMA achieved less than 100% of the Targeted EBITDA for the First Grant Year, the portion that is not deemed Earned Performance
Shares based on the achievement by HMA of the EBITDA Requirement during the First Grant Year will be carried over to the Second Grant Year and will be eligible for vesting if 100% or more of the Targeted EBITDA for the Second Grant Year is achieved.
The amount, if any, that becomes eligible for vesting pursuant to this Section 4(b) is referred to herein as the “Additional Earned Performance Shares.” The Additional Earned Performance Shares will vest as follows: 
 (i) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Third Grant Year, one-half of the
Additional Earned Performance Shares will vest on March 1 of the Third Grant Year; 
  

 3 

 (ii) provided that you have remained an Eligible Person at all times from the Date of Grant until
March 1 of the Fourth Grant Year, an additional one-fourth of the Additional Earned Performance Shares will vest on March 1 of the Fourth Grant Year; and 
 (iii) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Fifth Grant Year, the remaining one-fourth of the Additional Earned Performance Shares will vest
on March 1 of the Fifth Grant Year. 
 (c) Example. By way of example only, if the Performance Vesting Component consists of
10,000 Performance Shares, and if HMA achieved 90% of the Targeted EBITDA with respect to the First Grant Year, the number of Earned Performance Shares with respect to the First Grant Year would be 5,000 (50% of 10,000 Performance Shares, based upon
the EBITDA Requirement set forth in Section 2(b)), and 1,250 Performance Shares would vest on each March 1 of the Second Grant Year through the Fifth Grant Year, assuming that you have remained an Eligible Person at all times through the
vesting dates. The 5,000 Performance Shares that were not deemed Earned Performance Shares with respect to the First Grant Year would be carried over to the Second Grant Year for possible vesting in accordance with Section 4(b). If HMA were to
achieve 100% or more of the Targeted EBITDA for the Second Grant Year, the latter 5,000 Performance Shares would become Additional Earned Performance Shares, and an additional 2,500 Performance Shares would vest on March 1 of the Third Grant
Year and an additional 1,250 Performance Shares would vest on March 1 of each of the Fourth Grant Year and the Fifth Grant Year, assuming that you have remained an Eligible Person at all times through the vesting dates. If HMA were to achieve
less than 100% of the Targeted EBITDA for the Second Grant Year, the 5,000 Performance Shares that were not deemed Earned Performance Shares with respect to the First Grant Year would be forfeited. 
 5. Cash Performance Award. Subject to the terms set forth in this Award Notice and the Plan, including Committee certification pursuant to
Section 6, the Cash Performance Award will vest and be paid as follows: 
 (a) Earned Cash Amount. At the conclusion of the First
Grant Year, all or a portion of the Cash Performance Award will be eligible for vesting and payment based upon the achievement by HMA of the EBITDA Requirement during the First Grant Year. The portion of the Cash Performance Award that is eligible
for vesting and payment based upon the achievement by HMA of the EBITDA Requirement during the First Grant Year is referred to herein as the “Earned Cash Amount.” The Earned Cash Amount will vest and be paid as follows: 
 (i) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Second Grant Year, one-fourth of
the total amount of the Earned Cash Amount will vest on March 1 of the Second Grant Year and will be paid to you as soon as administratively practicable thereafter, but in no event later than March 31 of the Second Grant Year; 

 

 4 

 (ii) provided that you have remained an Eligible Person at all times from the Date of Grant until
March 1 of the Third Grant Year, an additional one-fourth of the total amount of the Earned Cash Amount will vest on March 1 of the Third Grant Year and will be paid to you as soon as administratively practicable thereafter, but in no
event later than March 31 of the Third Grant Year; 
 (iii) provided that you have remained an Eligible Person at all times from the
Date of Grant until March 1 of the Fourth Grant Year, an additional one-fourth of the total amount of the Earned Cash Amount will vest on March 1 of the Fourth Grant Year and will be paid to you as soon as administratively practicable
thereafter, but in no event later than March 31 of the Fourth Grant Year; and 
 (iv) provided that you have remained an Eligible
Person at all times from the Date of Grant until March 1 of the Fifth Grant Year, the remaining one-fourth of the total amount of the Earned Cash Amount will vest on March 1 of the Fifth Grant Year and will be paid to you as soon as
administratively practicable thereafter, but in no event later than March 31 of the Fifth Grant Year. 
 (b) Additional Earned Cash
Amount. In the event that all or any portion of the total amount of the Cash Performance Award is not deemed Earned Cash Amount because HMA achieved less than 100% of the Targeted EBITDA for the First Grant Year, the portion that is not deemed
Earned Cash Amount based on the achievement by HMA of the EBITDA Requirement during the First Grant Year will be carried over to the Second Grant Year and will be eligible for vesting and payment if 100% or more of the Targeted EBITDA for the Second
Grant Year is achieved. The amount, if any, that becomes eligible for vesting and payment pursuant to this Section 5(b) is referred to herein as the “Additional Earned Cash Amount.” The Additional Earned Cash Amount will vest and be
paid as follows: 
 (i) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the
Third Grant Year, one-half of the Additional Earned Cash Amount will vest on March 1 of the Third Grant Year and will be paid to you as soon as administratively practicable thereafter, but in no event later than March 31 of the Third Grant
Year; 
 (ii) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the Fourth Grant
Year, an additional one-fourth of the Additional Earned Cash Amount will vest on March 1 of the Fourth Grant Year and will be paid to you as soon as administratively practicable thereafter, but in no event later than March 31 of the Fourth
Grant Year; and 
 (iii) provided that you have remained an Eligible Person at all times from the Date of Grant until March 1 of the
Fifth Grant Year, the remaining one-fourth of the Additional Earned Cash Amount will vest on March 1 of the Fifth Grant Year and will be paid to you as soon as administratively practicable thereafter, but in no event later than March 31 of
the Fifth Grant Year. 
  

 5 

 (c) Example. By way of example only, if the total amount of the Cash Performance Award is $40,000,
and if HMA achieved 97.5% of the Targeted EBITDA with respect to the First Grant Year, the Earned Cash Amount with respect to the First Grant Year would be $36,000 (90% of $40,000, based upon the EBITDA Requirement set forth in Section 2(b)),
and assuming that you have remained an Eligible Person at all times through the vesting dates, $9,000 would vest on each March 1 of the Second Grant Year through the Fifth Grant Year and would be paid as soon as administratively practicable
following each vesting date, but in no event later than the March 31 immediately following each vesting date. The $4,000 that was not deemed Earned Cash Amount with respect to the First Grant Year would be carried over to the Second Grant Year
for possible vesting and payment in accordance with Section 5(b). If HMA were to achieve 100% or more of the Targeted EBITDA for the Second Grant Year, the $4,000 would become Additional Earned Cash Amount, and assuming that you have remained
an Eligible Person at all times through the vesting dates, $2,000 would vest on March 1 of the Third Grant Year and additional $1,000 on March 1 of the each of the Fourth Grant Year and the Fifth Grant Year, and would be paid as soon as
administratively practicable following each vesting date, but in no event later than the March 31 immediately following each vesting date. If HMA were to achieve less than 100% of the Targeted EBITDA for the Second Grant Year, the $4,000 that
was not deemed Earned Cash Amount with respect to the First Grant Year would be forfeited. 
 6. Committee Certification. As soon as
practicable following the end of the First Grant Year (and if applicable, the Second Grant Year), the Committee will determine and certify in writing if the EBITDA Requirement was satisfied, and the Earned Performance Shares (and if applicable, the
Additional Earned Performance Shares) and the Earned Cash Amount (and if applicable, the Additional Earned Cash Amount), if any, to be vested and paid based on the certified levels of performance. 
 7. Effect of Death, Termination or Retirement. Without limiting the vesting and payment requirements set forth in Sections 3, 4 and 5, in the
event of the termination of your employment with HMA prior to the complete vesting of the Award, or if you are otherwise not an Eligible Person prior to the complete vesting of the Award, any and all unvested and unpaid amounts or shares of Common
Stock underlying the Restricted Stock Award, including unvested dividends, will be forfeited and will not vest or be paid. Notwithstanding the foregoing, in the event of your termination of employment with HMA: (a) because of your retirement
from HMA at or after the age of 62, the Award will continue to vest and be paid following the date of your retirement in the manner and on the dates set forth above; provided, however, that you will not be entitled to any shares of Common Stock
underlying the Performance Vesting Component, including unvested dividends, or any amount of the Cash Performance Award, that would have otherwise become vested following your retirement; and (b) because of your death or total and permanent
disability, the Award will continue to vest and be paid in the manner and on the dates set forth above for a period of 36 months after the date of your termination of employment, and any unvested portion of the Award at the conclusion of such
36-month period will be forfeited; provided, however, that you or your beneficiary will not be entitled to any shares of Common Stock underlying the Performance Vesting Component, including unvested dividends, or any amount of the Cash Performance
Award, that would have otherwise become vested following your death or total and permanent disability. 
  

 6 

 8. Effect of Change in Control. Upon the occurrence of a Change in Control of HMA, your rights
will be determined in accordance with Section 9 of the Plan. For purposes of the Performance Vesting Component and the Cash Performance Award, the EBITDA Requirement will be deemed to have been satisfied at a level of 100%. 
 9. Effect of Breach of Non-Competition Agreement. Notwithstanding any other provision of this Award Notice, the unvested or unpaid portion of the
Award shall be forfeited on the day on which you breach any provision of Section 10. 
 10. [THIS SECTION 10 IS INCLUDED IN AWARD
NOTICES AS DEEMED APPROPRIATE] 
 Non-Competition and Related Covenants. In consideration of the grant of the Award, you covenant
and agree to observe each of the following promises: 
 (a) Non-Competition. 
 (i) You will not during employment and for 12 months after the termination of employment for any reason, directly or indirectly (whether as director,
stockholder, owner, partner, consultant, principal, employee, agent or otherwise): (A) compete against an Employer in the business of owning, leasing, acquiring or operating hospitals, health care facilities, or related entities in markets
which an Employer currently serves or has identified as a market an Employer plans to serve; or (B) accept employment with or otherwise perform services that an Employer performs for any hospital, health care facility, or related entity that an
Employer, or its related companies lease or manage. 
 (ii) Notwithstanding the terms and conditions of Section 10(a)(i) to the
contrary, HMA covenants and agrees that the restrictions on competition and acceptance of subsequent employment contained therein shall not apply if your employment is terminated by an Employer for reasons other than cause. 
 (b) Non-solicitation/Employer Interests. During your employment and for 12 months after the termination of your employment for any reason, you
will not, directly or indirectly (whether as director, stockholder, owner, partner, consultant, principal, employee, agent or otherwise): (i) solicit, induce, entice, hire, employ or attempt to employ any individual employed by an Employer as
of the termination of your employment or during the prior year; or (ii) take any action which is intended, or would reasonably be expected to, adversely affect an Employer, its business, reputation, or its relationship with its clients or
prospective clients, vendors, or other service providers, or any individual or entity with which an Employer maintains a business relationship. 
 (c) Non-Disclosure. You will hold all of each Employer’s Confidential Information in strictest confidence, and use it solely for the purpose of performing your duties for an Employer and for no other purpose. You will not
otherwise, directly or indirectly, take, publish, use or disclose any of an Employer’s Confidential Information during your employment or thereafter, except as may be required by law; provided, that you have first given prompt written notice to
the Employer of such legal requirement in enough time for the Employer to obtain an appropriate protective order or other remedy. 
  

 7 

 (d) Damages. You acknowledge that damages to an Employer resulting from any breach of this
Section 10 will be substantial but difficult to ascertain. You therefore agree to indemnify and hold harmless HMA and its directors, stockholders, and affiliated companies from and against any and all claims, suits, obligations, liabilities and
expenses (including without limitation attorneys’ fees and expenses) arising out of or relating to any breach or nonperformance of the covenants and obligations set forth in this Section 10. You further agree that this provision for
damages shall not limit or impair in any way an Employer’s right to obtain other remedies, or injunctive or other equitable relief, as specified herein. 
 (e) Enforcement. You acknowledge that without limiting the provisions of Section 10(d), if you violate this Section 10, an Employer will suffer irreparable harm and have no adequate remedy at law. You
therefore consent to enforcement of this Award Notice by means of a temporary injunction or other appropriate equitable relief in any competent court, without the necessity of proving the inadequacy of money damages, which shall be in addition to
any other remedies an Employer may have under this Award Notice or otherwise. You hereby submit to the jurisdiction of the Courts of the State of Florida for the purpose of such enforcement. You hereby waive, and agree not to assert, as a defense in
any such action or proceeding, any claim that you were not subject thereto or that venue is improper for lack of residence, inconvenient forum or otherwise. You agree that service of process may be made upon you by certified mail at your address
last known to HMA, and you waive your right to a jury trial. 
 (f) Terminology. For purposes of this Section 10, the term
“Confidential Information” shall include trade secrets, know-how and other information that is disclosed to or acquired by you during or in the course of your employment that relates to the business of an Employer and is not generally
available to the public or generally known in the industry in which an Employer is, or may become engaged, including without limitation, any formulas, patterns, devices, inventions, methods, techniques or processes, or combinations thereof, or
compilations of information, records and specifications, acquisition and development data, which are owned by an Employer and regularly used in the operation of its business and any other information of an Employer relating to its services (offered
or to be offered), research, development, marketing, pricing, customers, clients and prospective customers and clients, suppliers and potential suppliers, business methods, strategies, financial condition, personnel, plans, policies or prospects.

 (g) Survival. The provisions of this Section 10 and your obligations hereunder shall survive any forfeiture of the Award or
any other termination of this Award Notice. 
 11. Performance Awards. The Performance Vesting Component and the Cash Performance
Award are intended to constitute Performance Awards under Section 8 of the Plan and will be interpreted and administered by the Committee consistent with this intention. 
 12. Miscellaneous. 
 (a) Plan
Controls. The Award is subject to all of the provisions of the Plan, which is hereby incorporated by reference, and is further subject to all the interpretations, amendments, rules and regulations that may from time to time be promulgated and
adopted by the Committee pursuant to the Plan. In the event of any conflict among the provisions of the Plan and this Award Notice, the provisions of the Plan will be controlling and determinative. 
  

 8 

 (b) Amendment. Except as otherwise provided by the Plan, HMA may only alter, amend or terminate
the Award with your consent. 
 (c) Limits on Transferability. The Award shall not be pledged, hypothecated or otherwise encumbered or
subject to any lien, obligation or liability to any party (other than HMA), or assigned or transferred other than by will or the laws of descent and distribution or to a Beneficiary upon your death. Upon any attempt to transfer, assign, pledge,
hypothecate or otherwise dispose of the Award or any right or privilege conferred thereby contrary to the provisions of this Award Notice and the Plan, or upon the sale or levy or attachment or similar process upon the rights and privileges
conferred thereby, the Award shall immediately become null and void. 
 (d) Book Entry Registration; Issuance of Shares. The
Restricted Stock Award will initially be evidenced by book-entry registration only, without the issuance of a certificate representing the shares of Common Stock underlying the Restricted Stock Award. Subject to Section 12(g) of this Award
Notice, upon the written determination by the Committee of the vesting of any shares of Common Stock subject to the Restricted Stock Award, HMA will issue a certificate representing such vested shares of Common Stock as promptly as practicable
following the date of vesting as determined by the Committee. The shares of Common Stock may be issued during your lifetime only to you, or after your death to your designated beneficiary, or, in the absence of such beneficiary, to your duly
qualified personal representative. 
 (e) Nonassignability. The shares of Common Stock underlying the Restricted Stock Award may not,
except as otherwise provided in the Plan, be sold, assigned, transferred, pledged, hypothecated, margined or otherwise encumbered in any way prior to the vesting of such shares, whether by operation of law or otherwise, except by will or the laws of
descent and distribution. After vesting, the sale or other transfer of the shares of Common Stock will be subject to applicable laws and regulations under the Securities Act of 1933. 
 (f) Rights as a Stockholder. Prior to the vesting of the shares of Common Stock subject to the Restricted Stock Award, you will have all of the
other rights of a stockholder with respect to the shares of Common Stock so awarded, including, but not limited to, the right to receive dividends, if any, as may be declared on such shares from time to time and the right to vote (in person or by
proxy) such shares at any meeting of HMA’s stockholders. Notwithstanding the foregoing, dividends paid with respect to those shares of Common Stock subject to the Restricted Stock Award that have not vested at the time of such dividend payment
will be held in the custody of HMA (pursuant to a rabbi trust, escrow or similar arrangement) and will be subject to the same restrictions that apply to the shares of Common Stock subject to the Restricted Stock Award with respect to which the
dividends are issued. Any such dividends will be paid to you, with interest, within 30 days of the date such shares of Common Stock subject to the Restricted Stock Award become vested in accordance with this Award Notice. 
  

 9 

 (g) Restrictions on Issuance of Shares. If at any time HMA determines that the listing,
registration or qualification of the shares of Common Stock underlying the Restricted Stock Award upon any securities exchange or under any state or federal law, or the approval of any governmental agency, is necessary or advisable as a condition to
the issuance of a certificate representing any vested shares of Common Stock subject to the Restricted Stock Award, such issuance may not be made in whole or in part unless and until such listing, registration, qualification or approval shall have
been effected or obtained free of any conditions not acceptable to HMA. 
 (h) No Right to Continued Employment. You understand that
this Award Notice does not constitute a contract of employment and that you or HMA may terminate your employment at any time, for any or no reason, with or without notice unless a specific term of employment has been agreed to in a separate writing
signed by a duly authorized corporate officer of HMA. Your right, if any, to continue to serve HMA as an employee or otherwise will not be enlarged or otherwise affected by this Award Notice. 
 (i) Severability. If any provision of this Award Notice shall be held unlawful or otherwise invalid or unenforceable in whole or in part by a
court of competent jurisdiction, such provision shall (i) be deemed limited to the extent that such court of competent jurisdiction deems it lawful, valid and/or enforceable and as so limited shall remain in full force and effect, and
(ii) not affect any other provision of this Award Notice or part thereof, each of which shall remain in full force and effect. If the making of any payment or the provision of any other benefit required under this Award Notice shall be held
unlawful or otherwise invalid or unenforceable by a court of competent jurisdiction, such unlawfulness, invalidity or unenforceability shall not prevent any other payment or benefit from being made or provided under this Award Notice, and if the
making of any payment in full or the provision of any other benefit required under this Award Notice in full would be unlawful or otherwise invalid or unenforceable, then such unlawfulness, invalidity or unenforceability shall not prevent such
payment or benefit from being made or provided in part, to the extent that it would not be unlawful, invalid or unenforceable, and the maximum payment or benefit that would not be unlawful, invalid or unenforceable shall be made or provided under
this Award Notice. 
 (j) Waiver. Any party’s failure to insist on compliance or enforcement of any provision of this Award
Notice shall not affect its validity or enforceability or constitute a waiver of future enforcement of that provision or of any other provision of this Award Notice. 
 (k) Rights of HMA and Subsidiaries. This Award Notice does not affect the right of HMA or any of its subsidiaries to take any corporate action whatsoever, including without limitation its right to recapitalize,
reorganize or make other changes in its capital structure or business, merge or consolidate, issue bonds, notes, shares of Common Stock or other securities, including preferred stock, or options therefor, dissolve or liquidate, or sell or transfer
any part of its assets or business. 
 (l) Rules of Construction. The headings given to the Sections of this Award Notice are solely
as a convenience to facilitate reference, and are not intended to narrow, limit or affect the substance or interpretation of the provisions contained herein. The reference to any statute, regulation or other provision of law shall be construed to
refer to any amendment to or successor of such provision of law. 
  

 10 

 (m) Governing Law. This Award Notice will be governed by and construed in accordance with the laws
of the State of Delaware, except as superseded by applicable federal law, without giving effect to its conflicts of law provisions. 
 (n)
Section 409A. The Award is intended to be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the treasury regulations promulgated and other official guidance issued thereunder, and
shall be administered and interpreted consistent with such intention. 
 (o) Recoupment Policy. Without limiting any other provision
hereof, the Award is subject to the Recoupment Policy for Incentive Compensation set forth in Article VI, Section 8 of HMA’s Corporate Governance Guidelines, as such policy or guidelines may be hereafter amended. 
 *        *        *        *        * 
 ACKNOWLEDGEMENT 
 The undersigned acknowledges receipt
of, and understands and agrees to be bound by, this Award Notice and the Plan. The undersigned further acknowledges that: (i) this Award Notice and the Plan set forth the entire understanding between him and HMA regarding the Award granted by
this Award Notice; (ii) this Award Notice and the Plan supersede all prior oral and written agreements on that subject; and (iii) cash dividends paid with respect to the shares of Common Stock subject to the Restricted Stock Award will be
held in the custody of HMA in the manner set forth in Section 12(f). 
  

			
	Dated:	 	  

	
	  

	Signature
	
	  

	Name (printed)

  

 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]